Detail Infos HaploMUD: Allo SCT + ident. GvHD Proph.
Universitätsklinikum FreiburgID: 265
EntitätALL
Therapie-Linie
R/R
Altersgruppe
18-70
Phase
II
Ein- / Auschlusskriterien
Incl.: ALL high risk according to ESMO guidelines; 10/10 HLA-matched unrelated donor and haploidentical (≥ 5/10 and ≤ 8/10 HLA) relative matched donor available at least 4 weeks after completion of induction and/or consolidation
Excl.: Availability of an HLA-identical sibling as donor source.
Arzt
Prof. Dr. J. Finke: (juergen.finke@uniklinik-freiburg.de)
Study Nurse
Renate Angerer: Telefon 0761/270 32922; (renate.angerer@uniklinik-freiburg.de)